NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

maverick_1,

Great post! It will be fun to watch how Merck's sp will respond to the news.

About the following, I don't see any PR from Merck claiming that SC version of keytruda in P3 met the primary ending points.

Merck,which recently announced its Keytruda SC candidate met the co-primary endpoints in an ongoing Phase III trial in certain non-small cell lung cancer patients.

I heard that Merck's patent for SC version of keytruda was rejected. I cannot find the news on this either. I did see Senators asked the patent office to scrutinize Merck's patent application though.

https://www.warren.senate.gov/oversight/letters/senators-warren-sanders-representatives-jayapal-and-porter-urge-uspto-to-scrutinize-mercks-abuse-of-patent-applications-for-cancer-drug-keytruda